Suivi de chimérisme des populations cellulaires myéloïdes chez des patients allogreffés atteints de leucémie aiguë myéloïde : étude lyonnaise

Childs, 1999, Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses, Blood, 94, 3234, 10.1182/blood.V94.9.3234 Bader, 2005, How and when should we monitor chimerism after allogeneic stem cell transplantation?, Bone Marrow Transplant, 35, 107, 10.1038/sj.bmt.1704715 Baron, 2006, Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning, Leukaemia, 20, 1690, 10.1038/sj.leu.2404335 Antin, 2001, Establishment of complete and mixed chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem meeting, Biol Blood Marrow Transplant, 7, 473, 10.1053/bbmt.2001.v7.pm11669214 Mothy, 2007, Predictive factors and impact of full donor T-cell chimerism after reduced intensity conditioning allogeneic stem cell transplantation, Haematologica, 92, 1004, 10.3324/haematol.10971 [5] Baron F, Baker JE, Strob R, Gooley TA, Sandmaier BM, Mickael B et al. Kinetics of engraftment in patients with hematological malignancies given allogeneic hematopoietic cell transplantation after non-myeloablative conditioning. Blood 2004;104:2254–62. Miura, 2006, Analysis of donor-type chimerism in lineage-specific cell populations after allogeneic myeloablative and non myeloablative stem cell transplantation, Bone Marrow Transplant, 1 Ri-Young Goh, 2009, Clinical utility of chimerism staus assessed by lineage specific short tandem repeat analysis: experience from four cases of allogeneic stem cell transplantation, Korean J Lab Med, 29, 277, 10.3343/kjlm.2009.29.4.277 Zeiser, 2005, Evaluation of immunomodulatory treatment based on conventional and lineage-specific analysis in patients with myeloid malignancies after myeloablative allogeneic haematopoietic cell transplantation, Leukemia, 19, 814, 10.1038/sj.leu.2403719 Borhäuser, 2009, Monitoring of donor chimerism in sorted CD34+ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantation, Haematologica, 94 Bacher, 2008, Minimal residual disease diagnostics in myeloid malignancies in the post transplant period, Bone Marrow Tranplant, 1 Miller, 1988, A simple salting out procedure for extracting DNA from human nucleated cells, Nucleic Acids Res, 16, 1215, 10.1093/nar/16.3.1215 Thiede, 1999, Rapid quantification of mixed chimerism using multiplex amplication of short tandem repeat markers and fluorescence detection, Bone Marrow Tranplant, 23, 1055, 10.1038/sj.bmt.1701779 Thiede, 2001, Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markers, Leukemia, 15, 293, 10.1038/sj.leu.2401953 Alizadeh, 2002, Quantitative assesment of hematopoietic chimerism after bone marrow transplantation by real time quantitative PCR, Blood, 99, 4618, 10.1182/blood.V99.12.4618 Conter, 2010, Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukaemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study, Blood, 115, 3206, 10.1182/blood-2009-10-248146 Tausing, 2010, Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34-fraction, Blood, 115